Articles in this Issue

• 

  Outsourcing: Choosing a Contract Manufacturing Organization

  March 08, 2018
  A continuing debate for established, emerging, and virtual biopharmaceutical companies is whether or not to outsource production to a CMO. At its core, the issue is about brand protection. While outsourcing can minimize your capital and labor costs, ... read more
• 

  Formulation: Creating Spray-Dried Dispersions to Improve API Solubility

  March 08, 2018
  API molecules intended for oral administration are often categorized using the Biopharmaceutical Classification System (BCS), which indicates the primary factors affecting API bioavailability and, subsequently, directs the formulation strategy ... read more
• 

  Market Trends: Trends in the Solid Oral Drug Delivery Market

  March 08, 2018
  In recent years, parenterally delivered biologics have increasingly penetrated the pharmaceutical market due to their growing use in regenerative and personalized medicine as well as the development of new biologics and biosimilars. Despite this ... read more
• 

  Formulation: Developing Fixed-Dose Combinations

  March 08, 2018
  Developing new drug products is very expensive, especially when formulating new chemical entities (NCEs). Many pharmaceutical companies are turning to FDCs as a way to reduce those development costs. An FDC is a drug product that combines two or more... read more
• 

  Eye on Excipients: Indian Pharmaceutical Excipient Market

  March 08, 2018
  Large pharmaceutical companies currently source less than 10 percent of the excipients they use from India and prefer to engage with suppliers located in developed pharmaceutical markets. However, the Indian excipients market is growing at 10 to 12 ... read more